P

Inventor

BOYD MICHAEL R

US71 patents
⚠️ This page may combine multiple inventors who share the name “BOYD MICHAEL R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

US HEALTH

32 patents
US6245737B1Jun 12, 2001

Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins

US HEALTH33 citations96
US6015876AJan 18, 2000

Method of using cyanovirins

US HEALTH25 citations96
US5843882ADec 1, 1998

Antiviral proteins and peptides

US HEALTH31 citations96
US5821081AOct 13, 1998

Nucleic acids encoding antiviral proteins and peptides, vectors and host cells comprising same, and methods of producing the antiviral proteins and peptides

US HEALTH29 citations96
US6428790B1Aug 6, 2002

Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use

US HEALTH35 citations93
US7884178B2Feb 8, 2011

Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use

US HEALTH9 citations84
US6193982B1Feb 27, 2001

Anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120

US HEALTH16 citations84
US6420336B1Jul 16, 2002

Methods of using cyanovirins topically to inhibit viral infection

US HEALTH13 citations82
US5962653AOct 5, 1999

Methods of obtaining antiviral proteins and antiviral peptides from Nostoc ellipsosporum

US HEALTH8 citations82
US5783598AJul 21, 1998

Antiretroviral naphthoquinone compounds compositions and uses thereof

US HEALTH14 citations79
US5869522AFeb 9, 1999

Antiviral naphthoquinone compounds, compositions and uses thereof

US HEALTH13 citations78
US7754420B2Jul 13, 2010

Methods of using cyanovirins to inhibit viral infection

US HEALTH5 citations74
US6743577B2Jun 1, 2004

Methods of using cyanovirins to inhibit viral infection

US HEALTH4 citations74
US6586392B2Jul 1, 2003

Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins

US HEALTH4 citations74
US5998587ADec 7, 1999

Anti-cyanovirin antibody

US HEALTH5 citations73
US5552550ASep 3, 1996

Monomeric Naphthylisoquinoline alkaloids and synthesis methods thereof

US HEALTH10 citations73
US7144918B2Dec 5, 2006

Biologically active macrolides, compositions, and uses thereof

US HEALTH4 citations72
US5859049AJan 12, 1999

Calanolide and related antiviral compounds, compositions, and uses thereof

US HEALTH7 citations72
US5578729ANov 26, 1996

Dimeric arylisoquinoline alkaloid compounds

US HEALTH6 citations72
US6780847B2Aug 24, 2004

Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins

US HEALTH7 citations71
US5591770AJan 7, 1997

Calanolide and related antiretroviral compounds, compositions, and uses thereof

US HEALTH10 citations71
US5571919ANov 5, 1996

Dimeric naphthylisoquinoline alkaloids and synthesis methods thereof

US HEALTH5 citations71
US7491798B2Feb 17, 2009

Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins

US HEALTH6 citations70
US5654432AAug 5, 1997

Process of preparing michellamine compounds

US HEALTH6 citations70
US5455251AOct 3, 1995

Michellamine antiviral agents, compositions, and treatment methods

US HEALTH5 citations70
US5599839AFeb 4, 1997

Antiviral composition

US HEALTH11 citations68
US7521475B2Apr 21, 2009

Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof

US HEALTH1 citations63
US7381744B1Jun 3, 2008

Method of treating osteoporosis comprising vacuolar-type (H+)-ATPase-inhibiting compounds

US HEALTH3 citations63
US7205334B2Apr 17, 2007

Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof

US HEALTH1 citations63
US7105169B2Sep 12, 2006

Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use

US HEALTH2 citations63
US7048935B2May 23, 2006

Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use

US HEALTH2 citations63
US6987096B1Jan 17, 2006

Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof

US HEALTH4 citations62

ADT PHARMACEUTICALS LLC

8 patents

YAZAKI NORTH AMERICA INC

3 patents

US ARMY

3 patents

ADT PHARMACEUTICALS INC

2 patents

NEKTAR THERAPEUTICS AL

1 patent

BOYD MICHAEL R

1 patent

Showing the top 50 of 71 patents by PatentIndex Score.